Login to Your Account



China cracks down on penalties for falsifying drug application data

By Cornelia Zou
Staff Writer

Friday, August 18, 2017

HONG KONG – Chinese regulators have clarified the legal consequences of data falsification in new drug and medical device applications, alarming the industry – both applicants for registration and research institutions – by raising falsification to the level of a criminal law violation.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription